Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Motley Fool Transcribing - ARS Pharma (SPRY) Q4 2025 Earnings Transcript
ARS Pharma (SPRY) Q4 2025 Earnings Transcript
The Motley Fool

Monday, March 9, 2026, at 8:30 a.m. ET Chief Executive Officer — Richard Lowenthal Chief Commercial Officer — Eric Karas Chief Financial Officer — Kathleen Scott Need a quote from a Motley Fool analyst? Email [email protected]…

khou.com - Jishnu Nair (Houston Business Journal) - Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible
Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible
khou.com

Houston Business Journal New Jersey-based Bristol Myers Squibb said it would create nearly 500 jobs at the site. HOUSTON — Another pharmaceutical heavyweight is considering Houston for its domestic manufacturing operations, following several…

marketbeat.com - Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Rating of 'Buy' by Analysts
Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Rating of 'Buy' by Analysts
MarketBeat

Shares of Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) have been assigned a consensus rating of 'Buy' from the seven brokerages that are currently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock…

scientificamerican.com - Ramin Skibba - This startup wants to make drugs in orbit. If it succeeds, it could transform the space economy
This startup wants to make drugs in orbit. If it succeeds, it could transform the space economy
Scientific American

A start-up's plan to run drug experiments and even develop pharmaceuticals in orbit is taking shape. If it works, it could mark a step toward developing new medicines and, ultimately, a burgeoning space-based manufacturing industry. The start-up in…

marketbeat.com - VIRGINIA RETIREMENT SYSTEMS ET Al Increases Stock Holdings in BridgeBio Pharma, Inc. $BBIO
VIRGINIA RETIREMENT SYSTEMS ET Al Increases Stock Holdings in BridgeBio Pharma, Inc. $BBIO
MarketBeat

VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 146.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 25,850 shares…

thehindu.com - The Hindu Bureau - KIA crosses 400 million passenger milestone in April
KIA crosses 400 million passenger milestone in April
The Hindu

Kempegowda International Airport (KIA), Bengaluru, crosses the 400 million passenger milestone since its Airport Opening Day (AOD), in April, 2026. The airport also registered a strong growth in the financial year 2025-26, driven by international…

thehindubusinessline.com - SRF: On The Road to Recovery
SRF: On The Road to Recovery
BusinessLine

SRF reported its Q4FY26 results in early May and provided a strong outlook. We had earlier recommended a hold on the stock in August 2025 because valuations were elevated at 44 times one-year forward earnings even when factoring for expectations of…

marketbeat.com - Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by Bessemer Group Inc.
Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by Bessemer Group Inc.
MarketBeat

Bessemer Group Inc. lifted its position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 861,152.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…

cnbc.com - Natasha Abellard - Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
CNBC

Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it can live up to the hype. Icotyde went to market after the Food and Drug Administration approved it in mid-March for…

fool.com - Pamela Kock - Heron Bay Doubles Down on Vontier, Buying 1.37 Million Shares
Heron Bay Doubles Down on Vontier, Buying 1.37 Million Shares
The Motley Fool

According to a Securities and Exchange Commission (SEC) filing dated May 13, 2026, Heron Bay Capital Management acquired an additional 1,370,006 shares of Vontier (VNT 2.40%), during the first quarter. The estimated transaction value is $52.76…

nbcnews.com - Trump's flavored vape push sparks backlash from some MAHA influencers and administration officials
Trump's flavored vape push sparks backlash from some MAHA influencers and administration officials
NBC News

The Trump administration's recent moves to make flavored e-cigarettes and vapes more widely available have caused a splintering among prominent voices in the MAHA movement and even some federal health officials. Health Secretary Robert F. Kennedy's…

smh.com.au - Colin Kruger - 'Collision with reality': The $100 billion downfall of an Aussie giant
'Collision with reality': The $100 billion downfall of an Aussie giant
The Sydney Morning Herald

CSL investors had already torched tens of billions of dollars of wealth on the biomedical giant before the year had even started, and a sense of panic must have set in when its chief executive, Dr Paul McKenzie, abruptly resigned the day before its…

marketbeat.com - Lawood & Co. Takes Position in AbbVie Inc. $ABBV
Lawood & Co. Takes Position in AbbVie Inc. $ABBV
MarketBeat

Lawood & Co. bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 12,555 shares of the company's…

marketbeat.com - AbbVie Inc. $ABBV Shares Acquired by Lockheed Martin Investment Management Co.
AbbVie Inc. $ABBV Shares Acquired by Lockheed Martin Investment Management Co.
MarketBeat

Lockheed Martin Investment Management Co. grew its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 12.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned…

marketbeat.com - Commerzbank Aktiengesellschaft FI Sells 10,690 Shares of AbbVie Inc. $ABBV
Commerzbank Aktiengesellschaft FI Sells 10,690 Shares of AbbVie Inc. $ABBV
MarketBeat

Commerzbank Aktiengesellschaft FI lessened its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 11.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 79,412 shares of the company's…

Receive a Daily briefing on Pharma Industry News

Get Started